Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month Continues With Medical Update Webinar Jun 15, 2016
Actinium Announces Strong Presence at Society of Nuclear Medicine and Molecular Imaging Annual Meeting Jun 9, 2016
Actinium to Present at BIO International Convention to Provide Updates on Actimab-A and Iomab-B Programs Jun 8, 2016
Actinium Pharmaceuticals Announces Positive Safety and Efficacy Results From Phase 1 Actimab-A Trial in Patients With Newly Diagnosed Acute Myeloid Leukemia and Provides Guidance on Plans for Phase 2 Clinical Trial Jun 1, 2016
Actinium Pharmaceuticals Announces Positive Safety and Efficacy Results From Phase 1 Actimab-A Trial in Patients With Newly Diagnosed Acute Myeloid Leukemia and Provides Guidance on Plans for Phase 2 Clinical Trial Jun 1, 2016
Actinium Announces Webinar to Discuss Results of the Actimab-A Phase 1 Trial and Key Findings From the HuM195-Alpha Program May 18, 2016
Actinium to Present at BIO International Convention and Provide Updates on Actimab-A and Iomab-B Programs May 10, 2016
Actinium to Host Webinar to Discuss SIERRA Trial -- Upcoming Pivotal, Phase 3 Clinical Study for Iomab-B Apr 25, 2016
UPDATE - Actinium Announces Selection of Zevacor Pharma, Inc. for Clinical Production and Supply of Iomab-B for Pivotal Phase 3 SIERRA Trial Apr 12, 2016
